These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21737272)

  • 21. Identification and structure-activity relationships of ortho-biphenyl carboxamides as potent Smoothened antagonists inhibiting the Hedgehog signaling pathway.
    Peukert S; Jain RK; Geisser A; Sun Y; Zhang R; Bourret A; Carlson A; Dasilva J; Ramamurthy A; Kelleher JF
    Bioorg Med Chem Lett; 2009 Jan; 19(2):328-31. PubMed ID: 19091559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Hedgehog signalling pathway as a therapeutic target in early breast cancer development.
    O'Toole SA; Swarbrick A; Sutherland RL
    Expert Opin Ther Targets; 2009 Sep; 13(9):1095-103. PubMed ID: 19659449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteins of the Hedgehog signaling pathway as therapeutic targets against cancer.
    Nehmé R; Mus-Veteau I
    Expert Rev Proteomics; 2010 Aug; 7(4):601-12. PubMed ID: 20653513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications.
    Yang L; Xie G; Fan Q; Xie J
    Oncogene; 2010 Jan; 29(4):469-81. PubMed ID: 19935712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of novel dimethylpyridazine derivatives as hedgehog signaling pathway inhibitors.
    Wang C; Zhu M; Lu X; Wang H; Zhao W; Zhang X; Dong X
    Bioorg Med Chem; 2018 Jul; 26(12):3308-3320. PubMed ID: 29739714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent inhibitors of the hedgehog signaling pathway.
    Brunton SA; Stibbard JH; Rubin LL; Kruse LI; Guicherit OM; Boyd EA; Price S
    J Med Chem; 2008 Mar; 51(5):1108-10. PubMed ID: 18275133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists.
    Tremblay MR; Nevalainen M; Nair SJ; Porter JR; Castro AC; Behnke ML; Yu LC; Hagel M; White K; Faia K; Grenier L; Campbell MJ; Cushing J; Woodward CN; Hoyt J; Foley MA; Read MA; Sydor JR; Tong JK; Palombella VJ; McGovern K; Adams J
    J Med Chem; 2008 Nov; 51(21):6646-9. PubMed ID: 18842035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, Palladium-Catalyzed Synthesis, and Biological Investigation of 2-Substituted 3-Aroylquinolin-4(1H)-ones as Inhibitors of the Hedgehog Signaling Pathway.
    Alfonsi R; Botta B; Cacchi S; Di Marcotullio L; Fabrizi G; Faedda R; Goggiamani A; Iazzetti A; Mori M
    J Med Chem; 2017 Feb; 60(4):1469-1477. PubMed ID: 28122186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of novel 4-(2-pyrimidinylamino)benzamide derivatives as highly potent and orally available hedgehog signaling pathway inhibitors.
    Xin M; Zhang L; Jin Q; Tang F; Wen J; Gu L; Cheng L; Zhao Y
    Eur J Med Chem; 2016 Mar; 110():115-25. PubMed ID: 26820554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and Evaluation of Aminothiazole Derivatives as Hedgehog Pathway Inhibitors.
    Sun C; Zhang Y; Lin L; Liu S; Wang R; Zang W; Meng W; Chen X
    Chem Biodivers; 2019 Dec; 16(12):e1900431. PubMed ID: 31609078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel 5,7-disubstituted 6-amino-5H-pyrrolo[3,2-b]pyrazine-2,3-dicarbonitriles, the promising protein kinase inhibitors with antiproliferative activity.
    Dubinina GG; Platonov MO; Golovach SM; Borysko PO; Tolmachov AO; Volovenko YM
    Eur J Med Chem; 2006 Jun; 41(6):727-37. PubMed ID: 16675067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity.
    Miller-Moslin K; Peukert S; Jain RK; McEwan MA; Karki R; Llamas L; Yusuff N; He F; Li Y; Sun Y; Dai M; Perez L; Michael W; Sheng T; Lei H; Zhang R; Williams J; Bourret A; Ramamurthy A; Yuan J; Guo R; Matsumoto M; Vattay A; Maniara W; Amaral A; Dorsch M; Kelleher JF
    J Med Chem; 2009 Jul; 52(13):3954-68. PubMed ID: 19469545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GDC-0449-a potent inhibitor of the hedgehog pathway.
    Robarge KD; Brunton SA; Castanedo GM; Cui Y; Dina MS; Goldsmith R; Gould SE; Guichert O; Gunzner JL; Halladay J; Jia W; Khojasteh C; Koehler MF; Kotkow K; La H; Lalonde RL; Lau K; Lee L; Marshall D; Marsters JC; Murray LJ; Qian C; Rubin LL; Salphati L; Stanley MS; Stibbard JH; Sutherlin DP; Ubhayaker S; Wang S; Wong S; Xie M
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5576-81. PubMed ID: 19716296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D3 analogues that contain modified A- and seco-B-rings as hedgehog pathway inhibitors.
    DeBerardinis AM; Raccuia DS; Thompson EN; Maschinot CA; Kyle Hadden M
    Eur J Med Chem; 2015 Mar; 93():156-71. PubMed ID: 25676864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors.
    Mulvihill MJ; Ji QS; Coate HR; Cooke A; Dong H; Feng L; Foreman K; Rosenfeld-Franklin M; Honda A; Mak G; Mulvihill KM; Nigro AI; O'Connor M; Pirrit C; Steinig AG; Siu K; Stolz KM; Sun Y; Tavares PA; Yao Y; Gibson NW
    Bioorg Med Chem; 2008 Feb; 16(3):1359-75. PubMed ID: 17983756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinolone-1-(2H)-ones as hedgehog signalling pathway inhibitors.
    Trinh TN; McLaughlin EA; Abdel-Hamid MK; Gordon CP; Bernstein IR; Pye V; Cossar P; Sakoff JA; McCluskey A
    Org Biomol Chem; 2016 Jul; 14(26):6304-15. PubMed ID: 27272335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of hedgehog signaling in ovarian cancer.
    Bhattacharya R; Kwon J; Ali B; Wang E; Patra S; Shridhar V; Mukherjee P
    Clin Cancer Res; 2008 Dec; 14(23):7659-66. PubMed ID: 19047091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heteroarylamide smoothened inhibitors: Discovery of N-[2,4-dimethyl-5-(1-methylimidazol-4-yl)phenyl]-4-(2-pyridylmethoxy)benzamide (AZD8542) and N-[5-(1H-imidazol-2-yl)-2,4-dimethyl-phenyl]-4-(2- pyridylmethoxy)benzamide (AZD7254).
    Yang B; Hird AW; Bodnarchuk MS; Zheng X; Dakin L; Su Q; Daly K; Godin R; Hattersley MM; Brassil P; Redmond S; John Russell D; Janetka JW
    Bioorg Med Chem; 2020 Jan; 28(2):115227. PubMed ID: 31862310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4.
    Mitchell SA; Danca MD; Blomgren PA; Darrow JW; Currie KS; Kropf JE; Lee SH; Gallion SL; Xiong JM; Pippin DA; DeSimone RW; Brittelli DR; Eustice DC; Bourret A; Hill-Drzewi M; Maciejewski PM; Elkin LL
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6991-5. PubMed ID: 19879134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and structure-activity-relationship of phenyl imidazoles as potent Smoothened antagonists.
    Cheng D; Han D; Gao W; Jing Q; Jiang J; Wan Y; Englund NP; Tuntland T; Wu X; Pan S
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6573-6. PubMed ID: 23036954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.